ライフサイエンスコーパス: trabeculoplasty

1 ional surgery and approximately 5% had laser trabeculoplasty.

2 asty may be a better option than argon laser trabeculoplasty.

3 trabecular meshwork (TM) treatment by laser trabeculoplasty.

4 asonable and safe alternative to argon laser trabeculoplasty.

5 analogues, topical steroids, and argon laser trabeculoplasty.

6 gle of resolution vision or worse), and more trabeculoplasty (52% vs. 30%) among microstent eyes.

7 ser trabeculoplasty, titanium sapphire laser trabeculoplasty and excimer laser trabeculotomy) have sh

8 Laser trabeculoplasty and glaucoma-filtering surgery are effic

9 proposed mechanisms of action of argon laser trabeculoplasty and selective laser trabeculoplasty, as

10 itiated with ocular hypotensive drops, laser trabeculoplasty and surgery may also be used to slow dis

11 Laser trabeculoplasty and trabeculectomy also narrow the range

12 n for the treatment sequences of argon laser trabeculoplasty and trabeculectomy, and that lower intra

13 n of risk factors for failure of argon laser trabeculoplasty and trabeculectomy, and the impact of co

14 Medical therapy, laser trabeculoplasty, and filtration surgery each have their

15 imental glaucoma was produced by argon laser trabeculoplasty, and visual fields were assessed with be

16 Laser trabeculoplasty appears to rely on this process to resto

17 Argon laser and selective laser trabeculoplasty are safe and effective procedures for lo

18 on laser trabeculoplasty and selective laser trabeculoplasty, as well as review current studies of th

19 Laser trabeculoplasty can reduce nocturnal IOP elevation in me

20 options for treating glaucoma include laser trabeculoplasty, cycloablation, trabeculectomy, and glau

21 glaucoma medications added, adjunctive laser trabeculoplasty, cyclodiode laser, or filtering surgery.

22 76 476 in 2005, but since 2005 the number of trabeculoplasties decreased 19% to 142 682 in 2012.

23 in whom pharmacologic treatment and/or laser trabeculoplasty do not suffice to control the intraocula

24 ificant for 4 of 6 procedures studied: laser trabeculoplasty (elasticity, -0.27; 95% confidence inter

25 Since the 1980s, laser trabeculoplasty has served as an effective way to lower

26 .01, 95% CI, 1.91-5.17) and past argon laser trabeculoplasty (HR 1.81, P < 0.01, 95% CI, 1.18-2.77).

27 Laser trabeculoplasty induces the expression and secretion of

28 gh there is good evidence that initial laser trabeculoplasty is just as effective as initial medical

29 sms by which argon laser and selective laser trabeculoplasty lower intraocular pressure are not known

30 Adjunctive laser trabeculoplasty (LT) is an alternative to topical medica

31 Laser trabeculoplasty (LTP) is routinely used to treat open-an

32 ts have surgical privileges to perform laser trabeculoplasty (LTP).

33 are a few circumstances when selective laser trabeculoplasty may be a better option than argon laser

34 From 2001 to 2005, the number of trabeculoplasties more than doubled from 75 647 in 2001

35 Laser trabeculoplasty of the anterior uveal region of the trab

36 ts with early glaucoma either to argon laser trabeculoplasty plus betaxolol (n = 129) or to no immedi

37 Between 2000 and 2010, the rate of laser trabeculoplasty procedures provided by ophthalmologists

38 used to assess nonsurgical care, while laser trabeculoplasty procedures were used to assess clinic-ba

39 The mechanism by which laser trabeculoplasty reduces elevated intraocular pressure in

40 coma medication, followed by selective laser trabeculoplasty (SLT) and eventually glaucoma surgery (T

41 d studies suggest a role for selective laser trabeculoplasty (SLT) as initial therapy for open-angle

42 e (IOP)-lowering efficacy of selective laser trabeculoplasty (SLT) as sole therapy for primary open-a

43 Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the

44 ure (IOP) outcomes following selective laser trabeculoplasty (SLT) in early open-angle glaucoma (OAG)

45 Selective laser trabeculoplasty (SLT) is a safe and effective treatment

46 cy and safety of 360 degrees selective laser trabeculoplasty (SLT) on medically uncontrolled open-ang

47 Selective laser trabeculoplasty (SLT) should be explored as a therapeuti

48 dicated, treatments included selective laser trabeculoplasty (SLT), laser peripheral iridotomy (LPI),

49 rates of resident-performed selective laser trabeculoplasty (SLT).

50 ety profile, and efficacy of selective laser trabeculoplasty (SLT).

51 nalyze the results of repeat selective laser trabeculoplasty (SLT).

52 previous acute angle closure attacks, laser trabeculoplasties, surgeries, or intraocular injections

53 l laser applications (micropulse diode laser trabeculoplasty, titanium sapphire laser trabeculoplasty

54 patients with previously failed argon laser trabeculoplasty treatment.

55 Laser trabeculoplasty, using either photocoagulative (argon an

56 Argon laser trabeculoplasty, using typical clinical treatment parame

57 centage of ophthalmologists performing laser trabeculoplasty was relatively stable (48% in 1995 to 50